Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cliffs Natural Resources Inc (CLF): One Metric You Should Be Watching

Page 1 of 2

Cliffs Natural Resources Inc (NYSE:CLF) investors should pay attention to an increase in hedge fund interest lately.

To the average investor, there are dozens of gauges shareholders can use to watch the equity markets. Two of the best are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the top hedge fund managers can trounce their index-focused peers by a superb amount (see just how much).

Equally as key, optimistic insider trading activity is another way to break down the stock market universe. There are lots of incentives for an insider to downsize shares of his or her company, but only one, very simple reason why they would initiate a purchase. Various academic studies have demonstrated the market-beating potential of this strategy if shareholders know what to do (learn more here).

Consequently, it’s important to take a peek at the latest action surrounding Cliffs Natural Resources Inc (NYSE:CLF).

What have hedge funds been doing with Cliffs Natural Resources Inc (NYSE:CLF)?

Heading into 2013, a total of 23 of the hedge funds we track were long in this stock, a change of 5% from the third quarter. With hedgies’ sentiment swirling, there exists a select group of notable hedge fund managers who were upping their holdings meaningfully.

These Are The Most Shorted S&P 500 StocksAccording to our comprehensive database, SAC Capital Advisors, managed by Steven Cohen, holds the largest position in Cliffs Natural Resources Inc (NYSE:CLF). SAC Capital Advisors has a $115.6 million position in the stock, comprising 0.6% of its 13F portfolio. Sitting at the No. 2 spot is D E Shaw, managed by D. E. Shaw, which held a $47.6 million call position; the fund has 0.1% of its 13F portfolio invested in the stock. Other peers with similar optimism include Ken Fisher’s Fisher Asset Management, and Dmitry Balyasny’s Balyasny Asset Management.

Now, key money managers have been driving this bullishness. Alyeska Investment Group, managed by Anand Parekh, created the largest position in Cliffs Natural Resources Inc (NYSE:CLF). Alyeska Investment Group had 19.2 million invested in the company at the end of the quarter. Alexander Mitchell’s Scopus Asset Management also initiated a $4.7 million position during the quarter. The following funds were also among the new CLF investors: Glenn Russell Dubin’s Highbridge Capital Management, Michael Novogratz’s Fortress Investment Group, and Chuck Royce’s Royce & Associates.

How have insiders been trading Cliffs Natural Resources Inc (NYSE:CLF)?

Insider buying is at its handiest when the company in focus has experienced transactions within the past half-year. Over the latest 180-day time period, Cliffs Natural Resources Inc (NYSE:CLF) has seen 1 unique insiders purchasing, and 5 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Cliffs Natural Resources Inc (NYSE:CLF). These stocks are Alliance Resource Partners, L.P. (NASDAQ:ARLP), Tahoe Resources Inc (NYSE:TAHO), Natural Resource Partners LP (NYSE:NRP), Compass Minerals International, Inc. (NYSE:CMP), and Titanium Metals Corp (NYSE:TIE). This group of stocks belong to the industrial metals & minerals industry and their market caps are closest to CLF’s market cap.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!